Robert L. Nussbaum - 11 Nov 2021 Form 4 Insider Report for Invitae Corp

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 Nov 2021
Net transactions value
-$350,371
Form type
4
Filing time
15 Nov 2021, 16:07:13 UTC
Previous filing
18 Aug 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Options Exercise $131,363 +13,269 +5.4% $9.90* 259,319 11 Nov 2021 Direct
transaction NVTA Common Stock Options Exercise $167,833 +16,406 +6.3% $10.23* 275,725 11 Nov 2021 Direct
transaction NVTA Common Stock Sale $649,568 -29,675 -11% $21.89* 246,050 11 Nov 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVTA Employee Stock Options (right to buy) Options Exercise $0 -13,269 -25% $0.000000 40,080 11 Nov 2021 Common Stock 13,269 $9.90 Direct F4
transaction NVTA Employee Stock Options (right to buy) Options Exercise $0 -16,406 -23% $0.000000 53,594 11 Nov 2021 Common Stock 16,406 $10.23 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021.
F2 Represents a weighted average sale price. Actual sale prices ranged from $21.62 to $22.30 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
F3 Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F4 The shares subject to this option are fully vested and exercisable.
F5 The shares subject to this option are fully vested and exercisable.